COSYNTROPIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cosyntropin, and what generic alternatives are available?
Cosyntropin is a drug marketed by Mylan Institutional and Sandoz and is included in three NDAs.
The generic ingredient in COSYNTROPIN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cosyntropin
A generic version of COSYNTROPIN was approved as cosyntropin by MYLAN INSTITUTIONAL on December 17th, 2009.
Summary for COSYNTROPIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Clinical Trials: | 25 |
| Patent Applications: | 1,378 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | COSYNTROPIN at DailyMed |
Recent Clinical Trials for COSYNTROPIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chongqing Medical University | N/A |
| Hill Dermaceuticals, Inc. | Phase 1/Phase 2 |
| Synteract, Inc. | Phase 1/Phase 2 |
Pharmacology for COSYNTROPIN
| Drug Class | Adrenocorticotropic Hormone |
Medical Subject Heading (MeSH) Categories for COSYNTROPIN
US Patents and Regulatory Information for COSYNTROPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | COSYNTROPIN | cosyntropin | INJECTABLE;INJECTION | 090574-001 | Dec 17, 2009 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz | COSYNTROPIN | cosyntropin | INJECTABLE;INJECTION | 202147-001 | Jun 29, 2012 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz | COSYNTROPIN | cosyntropin | SOLUTION;INTRAVENOUS | 022028-001 | Feb 21, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
